A Placebo Controlled, Single-blind, Randomized, Multi-center Phase 2B Study to Determine the Efficacy and Safety of TissueGene-C, an Allogeneic Human Chondrocytes Expressing TGF-b1, in Patients With Degenerative Arthritis
Phase of Trial: Phase II
Latest Information Update: 11 May 2015
At a glance
- Drugs Tonogenchoncel-L (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Kolon Life Science
- 11 May 2015 According to a TissueGene media release, data from this study were presented at the 18th meeting of the American Society of Gene & Cell Therapy (ASGCT) 2015.
- 11 May 2015 According to a TissueGene media release, data from this study were presented at the 12th World Congress of the International Cartilage Repair Society (ICRS) 2015.
- 14 Nov 2012 TissueGene announces recruitment completion in a media release.